Our Priorities

Development and commercialization of new, attractive APIs is the priority of the POLPHARMA API R&D Department. The key to our success is the combination of experience and expertise of our own research team as well as effective co-operation with scientific institutions.

Highly qualified Professionals in technology development as well as in development in the field of Solid State Chemistry are employed in API R&D Department:

5

R&D Management
(including Planning)

3

Project
Management

13

New Process
Development

4

Process Improvement
Laboratory

22

Analytical Development
Laboratory

13

New Process
Development

In order to provide the best expertise, we created strategic partnerships:

Integrated network with external competency centers

Our strategy is based on partnerships which form and strengthen technology platforms for long-term growth, creating value for our customers.

Partnerships with other companies and development houses offer new technologies, identify the best projects and drive costs down with environmental sustainability.

 
SPECTRUM OF CHEMISTRY PROCESS CAPABILITIES
prev next

Competitive competences

We deliver a broad range of added value services to your business:

  • First generic launch - Technology development strategy for IP-regulated markets

  • Technology development strategy for early launch in non-IP and non-regulated markets

  • API differentiation – Solutions for new or mature API for line extension as well as generic launch in line with innovator (solid state chemistry, pro-drug, chiral compounds, adducts) in FDF development

 
OK